|
Clinicopathological features
|
n
|
AM expression
|
|---|
| | |
-
|
+
|
++
|
+++
|
P value
|
|---|
|
Age(years)
| | | | | |
0.705
|
|
< 55
|
56
|
5
|
18
|
12
|
21
| |
|
≥ 55
|
40
|
3
|
9
|
9
|
19
| |
|
Histotype
| | | | | |
0.155
|
|
Serous
|
75
|
7
|
17
|
17
|
34
| |
|
Non serous
|
21
|
1
|
10
|
4
|
6
| |
|
Residual tumor after initial laparotomy
| | | | | |
0.000*
|
|
< 1 cm
|
42
|
1
|
21
|
10
|
10
| |
|
≥ 1 cm
|
53
|
7
|
6
|
11
|
29
| |
|
Undetermined
|
1
|
0
|
0
|
0
|
1
| |
|
Differentiation
| | | | | |
0.199
|
|
Well-differentiated
|
27
|
4
|
11
|
6
|
6
| |
|
Moderately-differentiated
|
23
|
1
|
8
|
3
|
11
| |
|
Poorly-differentiated
|
39
|
3
|
7
|
11
|
18
| |
|
Undetermined
|
7
|
0
|
1
|
1
|
5
| |
|
FIGO staging
| | | | | |
0.003*
|
|
I
|
17
|
1
|
10
|
1
|
5
| |
|
II
|
19
|
0
|
10
|
4
|
5
| |
|
III
|
53
|
6
|
7
|
13
|
27
| |
|
IV
|
7
|
1
|
0
|
3
|
3
| |
|
Serum CA125
| | | | | |
0.301
|
|
≥ 500
|
52
|
5
|
11
|
13
|
23
| |
|
< 500
|
41
|
3
|
16
|
7
|
15
| |
|
Undetermined
|
3
|
0
|
0
|
1
|
2
| |
- *P < 0.05
- EOC = epithelial ovarian cancer; AM = Adrenomedullin; FIGO = International Federation of Gynecology and Obstetrics
